Prospect Venture Partners Lp - Net Worth and Insider Trading

Prospect Venture Partners Lp Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Prospect Venture Partners Lp owns 3 companies in total, including Vitae Pharmaceuticals Inc (VTAE) , Infinity Pharmaceuticals Inc (INFIQ) , and Senomyx Inc (SNMX) .

Click here to see the complete history of Prospect Venture Partners Lp’s form 4 insider trades.

Insider Ownership Summary of Prospect Venture Partners Lp

Ticker	Comapny	Transaction Date	Type of Owner
VTAE	Vitae Pharmaceuticals Inc	2015-03-24	10 percent owner
INFIQ	Infinity Pharmaceuticals Inc	2006-09-12	10 percent owner
SNMX	Senomyx Inc	2004-06-25	10 percent owner

Prospect Venture Partners Lp Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Prospect Venture Partners Lp Ownership Network

Ownership Network List of Prospect Venture Partners Lp

No Data

Ownership Network Relation of Prospect Venture Partners Lp

Prospect Venture Partners Lp Owned Company Details

What does Vitae Pharmaceuticals Inc do?

Who are the key executives at Vitae Pharmaceuticals Inc?

Prospect Venture Partners Lp is the 10 percent owner of Vitae Pharmaceuticals Inc. Other key executives at Vitae Pharmaceuticals Inc include Chief Financial Officer Richard Steven Morris , General Counsel Scott Applebaum , and Chief Medical Officer Carole Sable .

Vitae Pharmaceuticals Inc (VTAE) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Vitae Pharmaceuticals Inc (VTAE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Vitae Pharmaceuticals Inc (VTAE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Vitae Pharmaceuticals Inc (VTAE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Vitae Pharmaceuticals Inc Insider Transactions

No Available Data

What does Infinity Pharmaceuticals Inc do?

Who are the key executives at Infinity Pharmaceuticals Inc?

Prospect Venture Partners Lp is the 10 percent owner of Infinity Pharmaceuticals Inc. Other key executives at Infinity Pharmaceuticals Inc include director & President & CEO Adelene Q Perkins , Chief Scientific Officer Stephane Peluso , and Chief Medical Officer Robert Jr. Ilaria .

Infinity Pharmaceuticals Inc (INFIQ) Insider Trades Summary

Over the past 18 months, Prospect Venture Partners Lp made no insider transaction in Infinity Pharmaceuticals Inc (INFIQ). Other recent insider transactions involving Infinity Pharmaceuticals Inc (INFIQ) include a net sale of 410,196 shares made by Adelene Q Perkins ,

In summary, during the past 3 months, insiders sold 0 shares of Infinity Pharmaceuticals Inc (INFIQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 410,196 shares of Infinity Pharmaceuticals Inc (INFIQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 410,196 shares.

Infinity Pharmaceuticals Inc (INFIQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Infinity Pharmaceuticals Inc Insider Transactions

No Available Data

What does Senomyx Inc do?

Who are the key executives at Senomyx Inc?

Prospect Venture Partners Lp is the 10 percent owner of Senomyx Inc. Other key executives at Senomyx Inc include director & President & CEO John Poyhonen , 10 percent owner Richard R Mashaal , and 10 percent owner Senvest Management, Llc .

Senomyx Inc (SNMX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Senomyx Inc (SNMX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Senomyx Inc (SNMX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Senomyx Inc (SNMX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Senomyx Inc Insider Transactions

No Available Data

Prospect Venture Partners Lp Mailing Address

Above is the net worth, insider trading, and ownership report for Prospect Venture Partners Lp. You might contact Prospect Venture Partners Lp via mailing address: 435 Tasso Street, Suite 200, Palo Alto Ca 94301.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.